<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:g="http://base.google.com/ns/1.0" xmlns:c="http://base.google.com/cns/1.0">
    <channel>
        <title><![CDATA[Immunotherapy]]></title>
        <description><![CDATA[Descriptions and reviews of books, products and treatments relating to environmental illnesses.]]></description>
        <link>http://www.ei-resource.org/</link>
                                        <item>
                                <guid>http://www.ei-resource.org/conventional%10orthodox-therapy-books/immunotherapy/the-promise-of-low-dose-naltrexone-therapy/</guid>
                <title><![CDATA[The Promise Of Low Dose Naltrexone Therapy]]></title>
                <link>http://www.ei-resource.org/conventional%10orthodox-therapy-books/immunotherapy/the-promise-of-low-dose-naltrexone-therapy/</link>                
                <description><![CDATA[
                                    <img src="http://www.ei-resource.org/images/stories/jreviews/tn/tn_3625_list_promiseofldn_1279907814.jpg"  border="0"  alt="The Promise Of Low Dose Naltrexone Therapy"  title="The Promise Of Low Dose Naltrexone Therapy"  align="left"  style="width: 75px; height: 112px"  />                                

	Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
	
	by Elaine A. Moore and Samantha Wilkinson
	
	
	Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in...                ]]></description>
                <category><![CDATA[Immunotherapy]]></category>
                <pubDate>Fri, 23 Jul 2010 10:56:00 +0100</pubDate>
                <g:id>3625</g:id>
                <g:publish_date>2010-07-23</g:publish_date>
                                                                            <g:image_link>http://www.ei-resource.org/images/stories/jreviews/3625_promiseofldn_1279907814.jpg</g:image_link>
                                                                                        
            </item>
                        </channel>
</rss>
